Hyperbaric Oxygen Therapy for Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) is a specialized treatment targeting inner ear tissue recovery through enhanced oxygen delivery. HBOT Supports mitochondrial function in damaged cochlear cells, helps neutralize free radicals, reduces hypoxic damage in inner ear structures, and potentially interrupts inflammatory cascades causing hearing loss.
Recommended complementary treatments often include corticosteroids and addressing underlying vascular or autoimmune conditions that might contribute to sudden hearing loss.
